ConductScience.org, home

Trial · NCT02009163

Results by group108

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Time to Relapse From Date of Randomization to Endpoint of The Randomized-withdrawal PeriodPlacebo (Randomized-withdrawal Period)NAInter-Quartile Range 55.0 to NAdays
Time to Relapse From Date of Randomization to Endpoint of The Randomized-withdrawal PeriodSPD489 (Randomized-withdrawal Period)NAInter-Quartile Range NA to NAdays
Change From Randomized-Withdrawal Baseline in The Number of Binge- Eating Days Per Week During The Randomized-withdrawal PeriodPlacebo (Randomized-withdrawal Period)0.63Standard Error 0.076days
Change From Randomized-Withdrawal Baseline in The Number of Binge- Eating Days Per Week During The Randomized-withdrawal PeriodSPD489 (Randomized--Withdrawal Period)0.02Standard Error 0.061days
Percent of Participants Within Each Category of The Clinical Global Impression-Severity of Illness (CGI-S) Scale at Endpoint of The Randomized-withdrawal PeriodPlacebo (Randomized-withdrawal Period)Normal, Not at All Ill45.0percentage of participants
Percent of Participants Within Each Category of The Clinical Global Impression-Severity of Illness (CGI-S) Scale at Endpoint of The Randomized-withdrawal PeriodSPD489 (Randomized-withdrawal Period)Normal, Not at All Ill81.6percentage of participants
Percent of Participants Within Each Category of The Clinical Global Impression-Severity of Illness (CGI-S) Scale at Endpoint of The Randomized-withdrawal PeriodPlacebo (Randomized-withdrawal Period)Borderline Mentally Ill10.7percentage of participants
Percent of Participants Within Each Category of The Clinical Global Impression-Severity of Illness (CGI-S) Scale at Endpoint of The Randomized-withdrawal PeriodSPD489 (Randomized-withdrawal Period)Borderline Mentally Ill11.8percentage of participants
Percent of Participants Within Each Category of The Clinical Global Impression-Severity of Illness (CGI-S) Scale at Endpoint of The Randomized-withdrawal PeriodPlacebo (Randomized-withdrawal Period)Mildly Ill14.5percentage of participants
Percent of Participants Within Each Category of The Clinical Global Impression-Severity of Illness (CGI-S) Scale at Endpoint of The Randomized-withdrawal PeriodSPD489 (Randomized-withdrawal Period)Mildly Ill2.2percentage of participants
Percent of Participants Within Each Category of The Clinical Global Impression-Severity of Illness (CGI-S) Scale at Endpoint of The Randomized-withdrawal PeriodPlacebo (Randomized-withdrawal Period)Moderately Ill22.1percentage of participants
Percent of Participants Within Each Category of The Clinical Global Impression-Severity of Illness (CGI-S) Scale at Endpoint of The Randomized-withdrawal PeriodSPD489 (Randomized-withdrawal Period)Moderately Ill2.2percentage of participants
Percent of Participants Within Each Category of The Clinical Global Impression-Severity of Illness (CGI-S) Scale at Endpoint of The Randomized-withdrawal PeriodPlacebo (Randomized-withdrawal Period)Markedly Ill6.9percentage of participants
Percent of Participants Within Each Category of The Clinical Global Impression-Severity of Illness (CGI-S) Scale at Endpoint of The Randomized-withdrawal PeriodSPD489 (Randomized-withdrawal Period)Markedly Ill2.2percentage of participants
Percent of Participants Within Each Category of The Clinical Global Impression-Severity of Illness (CGI-S) Scale at Endpoint of The Randomized-withdrawal PeriodPlacebo (Randomized-withdrawal Period)Severely Ill0.0percentage of participants
Percent of Participants Within Each Category of The Clinical Global Impression-Severity of Illness (CGI-S) Scale at Endpoint of The Randomized-withdrawal PeriodSPD489 (Randomized-withdrawal Period)Severely Ill0.0percentage of participants
Percent of Participants Within Each Category of The Clinical Global Impression-Severity of Illness (CGI-S) Scale at Endpoint of The Randomized-withdrawal PeriodPlacebo (Randomized-withdrawal Period)Among the Most Extremely Ill0.8percentage of participants
Percent of Participants Within Each Category of The Clinical Global Impression-Severity of Illness (CGI-S) Scale at Endpoint of The Randomized-withdrawal PeriodSPD489 (Randomized-withdrawal Period)Among the Most Extremely Ill0.0percentage of participants
Change From Randomized-Withdrawal Baseline in The Total Score of The Yale-Brown Obsessive Compulsive Scale Modified for Binge Eating (Y-BOCS-BE) During The Randomized-withdrawal PeriodPlacebo (Randomized-withdrawal Period)5.5Standard Error 0.66units on a scale
Change From Randomized-Withdrawal Baseline in The Total Score of The Yale-Brown Obsessive Compulsive Scale Modified for Binge Eating (Y-BOCS-BE) During The Randomized-withdrawal PeriodSPD489 (Randomized-withdrawal Period)-0.0Standard Error 0.52units on a scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02009163/results